Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
21.90
-0.09 (-0.41%)
At close: Dec 5, 2025, 4:00 PM EST
21.27
-0.63 (-2.87%)
After-hours: Dec 5, 2025, 7:13 PM EST
Elanco Animal Health Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Elanco Animal Health stock have an average target of 21.13, with a low estimate of 13 and a high estimate of 27. The average target predicts a decrease of -3.52% from the current stock price of 21.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elanco Animal Health stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 4 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Keybanc | Keybanc | Buy Initiates $27 | Buy | Initiates | $27 | +23.29% | Nov 21, 2025 |
| UBS | UBS | Strong Buy Maintains $25 → $27 | Strong Buy | Maintains | $25 → $27 | +23.29% | Nov 6, 2025 |
| UBS | UBS | Strong Buy Maintains $19 → $25 | Strong Buy | Maintains | $19 → $25 | +14.16% | Oct 20, 2025 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $18 → $24 | Hold → Buy | Upgrades | $18 → $24 | +9.59% | Oct 7, 2025 |
| Stifel | Stifel | Strong Buy Maintains $18 → $23 | Strong Buy | Maintains | $18 → $23 | +5.02% | Sep 24, 2025 |
Financial Forecast
Revenue This Year
4.76B
from 4.44B
Increased by 7.19%
Revenue Next Year
5.01B
from 4.76B
Increased by 5.32%
EPS This Year
0.95
from 0.68
Increased by 40.25%
EPS Next Year
1.05
from 0.95
Increased by 9.93%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.0B | 5.3B | ||||
| Avg | 4.8B | 5.0B | ||||
| Low | 4.5B | 4.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 11.8% | 10.5% | ||||
| Avg | 7.2% | 5.3% | ||||
| Low | 1.8% | -0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 1.10 | 1.17 | ||||
| Avg | 0.95 | 1.05 | ||||
| Low | 0.88 | 0.96 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 62.1% | 22.2% | ||||
| Avg | 40.3% | 9.9% | ||||
| Low | 29.7% | 0.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.